(Bloomberg) -- Bayer AG’s new chief executive said he’s weighing a breakup of the pharma and agriculture conglomerate, a move that could undo much of the legacy of his predecessor, including the troubled acquisition of Monsanto.Most Read from BloombergRockstar Plans to Announce Much Anticipated ‘Grand Theft Auto VI’Trump's Wealth Has Jumped $500 Million Since He Left the White HouseXi to Meet US Business Leaders for Dinner in San FranciscoWeWork Goes Bankrupt, Signs Pact With Creditors to Cut De